window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-678R680DW0');


Perdigó attends Pharmapack 2023 conference in Paris

January 24, 2023|

Ever since its launch in 1997, Pharmapack has been one of the key meeting places for the pharma packaging & drug delivery industry, gaining a great worldwide reputation. It is a key meeting place to find new partners and develop new collaborations, [...]

Perdigó sponsors DDL 2022 conference in Edinburgh

November 3, 2022|

Perdigó is pleased to announce it is sponsoring this year’s Drug Delivery to the Lungs (DDL2022) conference being held in Edinburgh, Scotland, from 7th to 9th December 2022. Perdigó is a high-calibre inhaler design & engineering house based in Barcelona. As [...]

Barcelona Health Hub interviews Arnau Perdigó

July 25, 2022|

Barcelona Health Hub (BHH) marketing team interviews Perdigó CEO Arnau Perdigó-Oliveras. He introduces Perdigó Medical, a highly ambitious and successful engineering services provider specialising in healthcare; he shares what makes the company stand out from competition and discusses early success cases [...]

Perdigó and NIBRT unveil AdvaCTS

April 14, 2022|

The Alliance for Regenerative Medicine’s  cell and gene therapy ’Meeting on the Med’ (CGMED22) is coming to Perdigó’s home city of Barcelona from the 12th to the 14th of April 2022. In this context, Perdigó is proud to unveil AdvaCTS: the [...]

Perdigó Joins CataloniaBio & HealthTech

February 16, 2021|

Perdigó is proud to announce it has joined  CataloniaBio and HealthTech, the organisation representing biomedicine companies and the health sector in Catalonia. The cluster brings together over 200 companies including pharmaceutical companies, hospitals, medical device and in vitro diagnostics companies, and [...]

Building a digital health solution

July 9, 2020|

Many Digital Health product companies, attracting record-breaking investment even half-way through 2020, are still focussed on generic, 'one size fits all' platforms. Take Wellthy Therapeutics, for example, who beat us at pitching a Digital Health solution for Pulmonary Arterial Hypertension (PAH) patients [...]

Go to Top